Treatment eligibility in Alaska Native and American Indian persons with hepatitis C virus infection

Treatment eligibility in Alaska Native and American Indian persons with hepatitis C virus infection

Objectives. Treatment with pegylated interferon and ribavirin may prevent progression of liver disease among patients with chronic hepatitis C virus infection (HCV). Treatment initiation is based on published clinical eligibility criteria, patients’ willingness to undergo treatment and li...

Full description

Bibliographic Details
Main Authors: Stephen E. Livingston, Lisa J. Townshend-Bulson, Dana L. Bruden, Brian J. McMahon, Chriss E. Homan, James E. Gove, Heike Deubner, Michael G. Bruce, Renee F. Robinson, David R. Gretch
Format: Article
Language:English
Published: Taylor & Francis Group 2012-04-01
Series:International Journal of Circumpolar Health
Subjects:
hepatitis C treatment
hepatology clinics
treatment eligibility
Online Access:http://www.circumpolarhealthjournal.net/index.php/ijch/article/view/18445/pdf_1

Internet

http://www.circumpolarhealthjournal.net/index.php/ijch/article/view/18445/pdf_1

Similar Items